Table:
begin	end	state
1	22	cytoplasmic
23	44	transmembrane
45	50	non-cytoplasmic
51	70	transmembrane
71	99	cytoplasmic
100	122	transmembrane
123	127	non-cytoplasmic
128	148	transmembrane
149	157	cytoplasmic
158	182	transmembrane
183	201	non-cytoplasmic
202	224	transmembrane
225	242	cytoplasmic
243	264	transmembrane
265	283	non-cytoplasmic
284	305	transmembrane
306	325	cytoplasmic
326	350	transmembrane
351	361	non-cytoplasmic
362	385	transmembrane
386	404	cytoplasmic
405	424	transmembrane
425	429	non-cytoplasmic
430	449	transmembrane
450	459	cytoplasmic

Input:
>WP_058932055.1 NCBI__GCF_001484605.1:WP_058932055.1
MTSKSTAVRPESHLGHTMKPRQLTMMGLGSAIGAGLFLGSGAGIQAAGPAVLISYLVAGT
LIILVMWALGEMAAANPTSGAFSVYAERALGKTAGATVGWLWWLQLVVVIAAEALGAAGL
LFSVWPAIPVWALALTFMVVFTAINLTGVKNFGEFEFWFAILKVAAIVAFLAVGAALLLG
LLPDVASPGLANITTDFAPAGLGGVATALFVVIFAFGGTEIVAVAAAETEDPEHSVGKAI
RTVLWRILVFYIGSVFVIAAVLPVSSEGLASPFAGVLDAARIPGAGTAITLVAVVALLSA
LNANLYGASRMVYSLAERGEAPRFLARLSGASVPMLAVGVSVAFGFFATVLELLFPDRIL
PALFQLVGSTCLVVWGTALVSQLILRRRADREGAELPLRMKGFPGLTICGLVLLGLIFAI
GFSAESSRGQLLSTFVLVACLAAACWLGARLTTRDRQPK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server